PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities?

    A. V. Atalyan, Eldar Sharifulin, Л. В. Лазарева, Yana Nadelyaeva, L. V. Suturina
    Image of study
    TLDR Hyperprolactinemia should be treated before confirming a PCOS diagnosis.
    The document discusses the complex relationship between hyperprolactinemia and PCOS, noting that although hyperprolactinemia is typically excluded in PCOS diagnosis, it has been found in some PCOS patients. The authors propose the term "potential PCOS" for cases with hyperprolactinemia until it is treated and symptoms are re-evaluated. They call for more research to understand the link between these conditions, including studies on asymptomatic hyperprolactinemia and macroprolactin. The review concludes that a definitive PCOS diagnosis should be made only after hyperprolactinemia is addressed and symptoms are reassessed.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 97 results

    Similar Research

    5 / 1000+ results
      Diagnosis and Management of Infertility Due to Anovulation

      research Diagnosis and Management of Infertility Due to Anovulation

      2 citations, March 2011 in “Infertility”
      The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.
      Endocrine Disorders and Infertility

      research Endocrine Disorders and Infertility

      1 citations, March 2011 in “Infertility”
      Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.
      Endocrinology

      research Endocrinology

      April 2023 in “Clinical Chemistry and Laboratory Medicine”
      The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.